Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease

Current Opinion in Pharmacology
Soni DeshwalNina Kaludercic

Abstract

In the past decade, accumulating evidence highlighted the role of monoamine oxidases (MAOs) in cardiovascular disease (CVD). MAOs are flavoenzymes located in the outer mitochondrial membrane, responsible for the degradation of neurotransmitters and biogenic amines. During this process they generate hydrogen peroxide, aldehydes and ammonia, species that can target mitochondria and induce mitochondrial dysfunction and cardiomyocyte death. Indeed, MAO inhibition affords cardioprotection in several models of CVD, such as ischemia/reperfusion, heart failure and diabetes. Importantly, a few studies provided encouraging results suggesting that MAO inhibition might be beneficial also in patients with CVD. Thus, selective and reversible MAO inhibitors, currently used as therapy for depression and neurodegenerative disorders, might be considered as candidate drugs for the treatment of CVD.

Citations

Sep 9, 2017·Exercise and Sport Sciences Reviews·John C Quindry, Barry A Franklin
Jul 14, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Kerstin BoenglerRainer Schulz
Apr 11, 2018·Journal of Neural Transmission·Keith F Tipton
Jul 11, 2019·The FEBS Journal·Maria Luisa Di PaoloAnna Minarini
Jul 13, 2019·Cardiovascular Research·Kristen J BubbGemma A Figtree
Jan 13, 2018·Expert Opinion on Therapeutic Patents·Simone CarradoriJacques P Petzer
Nov 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Isabella BologninoMarco Catto
Sep 25, 2020·Molecular Diversity·Stephanus J CloeteJacobus P Petzer
Mar 7, 2020·Frontiers in Cardiovascular Medicine·Nina Kaludercic, Fabio Di Lisa
Jun 11, 2019·Oxidative Medicine and Cellular Longevity·Adrian SturzaEugen S Boia
Oct 21, 2019·Pharmacology & Therapeutics·Michael Bader
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Jing LiuLei Shao
Feb 9, 2021·Cell Calcium·Salvatore AntonucciNina Kaludercic
Dec 31, 2020·Bioorganic Chemistry·Valeria A PanovaKyrill Yu Suponitsky
Dec 3, 2020·American Journal of Respiratory Cell and Molecular Biology·Xiao-Qing SunHarm Jan Bogaard
Apr 10, 2021·Journal of Chemical Neuroanatomy·Danielle N Jones, Mary Ann Raghanti
Apr 29, 2021·Free Radical Biology & Medicine·Nikole J ByrneHeiko Bugger
May 5, 2021·Drug Metabolism Reviews·Nikhilesh V DhuriaJasleen K Sodhi
May 18, 2021·Frontiers in Pharmacology·Mahyar Ostadkarampour, Edward E Putnins
May 22, 2021·Free Radical Biology & Medicine·David Weissman, Christoph Maack
Jul 3, 2021·Fundamental & Clinical Pharmacology·Banafshe AbadiHamid-Reza Rahimi
Jul 28, 2018·Langmuir : the ACS Journal of Surfaces and Colloids·Liulin WangNam-Joon Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.